Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.44492 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.39406 | 16 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.39702 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.34554 | 16 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.33881 | 16 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.48442 | 18 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.41335 | 16 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.37188 | 16 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.33215 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.38011 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.37742 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.37178 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.38307 | 16 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.3815 | 16 |